Thursday, July 30, 2026
Biotech

Hims & Hers Faces Legal Battle, Stock Drops

Hims & Hers stock fell 10% after the FTC sued the company over data sharing and billing issues.

Hims & Hers, a telehealth company, saw its stock drop. The Federal Trade Commission (FTC) sued the company. This action by the FTC made investors nervous.

The FTC claims Hims & Hers shared health data with Meta and Snap. This could be a big privacy concern. The lawsuit also points to problems with how the company bills customers. It also raises questions about canceling subscriptions.

Doctors and patients use telehealth more and more. Trust in these services is very important. This lawsuit brings up serious questions about patient privacy and fair business practices.

This legal fight could impact Hims & Hers' future. It also serves as a warning for other telehealth companies. They must handle patient data with care. They must also be clear about their billing and cancellation policies.

Source: CNBC

#Biotech#Lawsuit#Privacy

More from Biotech